Johnson & Johnson’s subsidiary Ethicon has reported positive results from two clinical studies conducted using its Echelon Flex Powered Staplers and new lung model, respectively, for thoracic surgery procedures in lung cancer cases.

Data, presented at the 26th European Society of Thoracic Surgeons meeting, demonstrated lower rates of bleeding complications, improved patients outcomes and decreased hospital costs.

The first real-world study compared the effect of powered staplers with that of manual devices during a video-assisted thoracoscopic surgery (VATS) for the cancer.

Published in Advances in Therapy, findings showed an almost 50% decrease in bleeding complications when Ethicon’s powered staplers were used.

“Data, presented at the 26th European Society of Thoracic Surgeons meeting, demonstrated lower rates of bleeding complications, improved patients outcomes and decreased hospital costs.”

In addition, total hospital costs were cut down by 10%, and patients were discharged one day sooner from the hospital.

Ethicon Thoracic Surgery senior medical director Edmund Kassis said: “We continue to take aim at critical clinical issues such as haemostasis complications through the development of innovative devices like Echelon Flex Powered Staplers and the generation of meaningful clinical and real-world evidence that fills knowledge gaps, validates outcomes and better informs everyday decision making.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The second study involved the company’s new ex-vivo lung model that successfully mimicked a person’s breathing under natural as well as ventilated settings.

Ethicon designed the new model to simulate various physiologic environments which are experienced by an isolated lung in the perioperative period.

This is intended to facilitate monitoring for researchers to determine the mechanism and causes behind air leaks, which is a post-operative complication known to take place in 24% of lobectomies.

The complication is said to lead to about a two times increase in hospital mortality.

Results from the lung model study, published in IEEE Transactions on Biomedical Engineering, are expected to allow researchers to explore potential approaches under clinically relevant conditions to decrease air leaks risk.